黄冈囊通过表观遗传疗法减轻糖尿病病的影响
Yihong Yu1,2, Haitao Tang3, Nan Li4
1Laboratory of Molecular Medicine, China Pharmaceutical University, Nanjing, China.
Frontiers in pharmacology
|March 12, 2026
概括
黄冈囊 (HKC) 通过恢复表观遗传机制来治疗糖尿病病 (DN). 这种中国草药使细胞中的DNA甲基化和基因表达正常化,提供保护.
科学领域:
- 药理学 药理学是指药理学的学科.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 黄冈囊 (HKC),来自*Abelmoschus manihot*,在治疗糖尿病病 (DN) 中显示出临床疗效.
- 虽然药理机制已被理解,但HKC在DN中的作用的表观遗传基础仍然不清楚.
研究的目的:
- 研究HKC改善糖尿病病的表观遗传机制.
- 在表观遗传层面上确定受HKC治疗影响的特定基因和途径.
主要方法:
- 使用了db/db小鼠模型的2型糖尿病和糖尿病病.
- 在4周内口服HKC,并对脏组织进行全基因组二硫酸盐测序和转录组分析.
主要成果:
- HKC显著降低了白蛋白尿,这表明脏受到保护.
- 通过调节*Tet2*表达,HKC调节了DNA甲基化模式,影响了5mC的分布.
- 鉴定了12个DN相关基因,在HKC治疗后具有逆甲基化和表达,与免疫调节,突触信号传递和Notch通路有关.
结论:
- 这项研究提供了首个证据,证明HKC在改善DN方面具有表观遗传治疗作用.
- 在DN中,HKC恢复脏基因的DNA甲基化和转录活性.
- 通过生物实验进行进一步的验证是有必要的,以证实这些表观遗传发现.
关键词:
阿贝尔莫斯克斯 (Abelmoschus) 马尼霍特 (L.) 植物通过DNA甲基化.糖尿病性脏病 糖尿病脏病表观遗传药理学是指表观遗传药理学转录基因组测序的转录基因组测序整个基因组二硫酸盐测序更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
1.0K
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
2.0K
相关概念视频
01:23Dipeptidyl Peptidase 4 Inhibitors
845
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
845
01:16Antihypertensive Drugs: Action of Diuretics
2.6K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.6K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
793
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
793
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K